Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Clotet

Showing results (211-220 of 263) with videos related to

Pageof 27
Sort By:
HIV Medicine|March 23, 2012
Condylomata, cytological abnormalities and human papillomavirus infection in the anal canal in HIV-infected menL Darwich, M P Cañadas, S Videla, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 8, 2000
High-dose saquinavir plus ritonavir: long-term efficacy in HIV-positive protease inhibitor-experienced patients and predictors of virologic responseR Paredes, T Puig, A Arnó, et al.
AIDS (London, England)|April 20, 1999
Protease inhibitor-containing regimens compared with nucleoside analogues alone in the suppression of persistent HIV-1 replication in lymphoid tissueL Ruiz, J van Lunzen, A Arno, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 9, 2000
Prevalence and route of transmission of infection with a novel DNA virus (TTV), hepatitis C virus, and hepatitis G virus in patients infected with HIVF Puig-Basagoiti, M Cabana, M Guilera, et al.
Medicina Clinica|May 15, 1998
[Recommendations on antiretroviral treatment. The AIDS Study Group of the Spanish Society of Infectious Diseases and Clinical Microbiology]S Moreno, J Arrizabalaga, J M Gatell, et al.
Antiviral Research|June 16, 2000
Genetic evolution of GB virus C/hepatitis G virus (GBV-C/HGV) under interferon pressureM Giménez-Barcons, A Sánchez-Fueyo, S Ampurdanés, et al.
Journal of Dental Research|July 20, 2021
Mouthwashes with CPC Reduce the Infectivity of SARS-CoV-2 Variants In VitroJ Muñoz-Basagoiti, D Perez-Zsolt, R León, et al.
HIV Medicine|April 6, 2005
Comparison of gastrointestinal tolerability and patient preference for treatment with the 625 mg and 250 mg nelfinavir tablet formulationsM Johnson, L Nieto-Cisneros, A Horban, et al.
AIDS (London, England)|May 12, 2000
Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain. The ERASE-2 Study GroupT Puig, M Pérez-Olmeda, A Rubio, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|December 3, 1998
[Recommendations for antiretroviral treatment in 1998. AIDS Working Group of the Spanish Society for Infectious Diseases and Clinical Microbiology (SEIMC)]S Moreno, J Arrizabalaga, J M Gatell, et al.
Pageof 27

Showing results (211-220 of 263) with videos related to

Sort By:
Pageof 27
HIV Medicine|March 23, 2012
Condylomata, cytological abnormalities and human papillomavirus infection in the anal canal in HIV-infected menL Darwich, M P Cañadas, S Videla, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 8, 2000
High-dose saquinavir plus ritonavir: long-term efficacy in HIV-positive protease inhibitor-experienced patients and predictors of virologic responseR Paredes, T Puig, A Arnó, et al.
AIDS (London, England)|April 20, 1999
Protease inhibitor-containing regimens compared with nucleoside analogues alone in the suppression of persistent HIV-1 replication in lymphoid tissueL Ruiz, J van Lunzen, A Arno, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 9, 2000
Prevalence and route of transmission of infection with a novel DNA virus (TTV), hepatitis C virus, and hepatitis G virus in patients infected with HIVF Puig-Basagoiti, M Cabana, M Guilera, et al.
Medicina Clinica|May 15, 1998
[Recommendations on antiretroviral treatment. The AIDS Study Group of the Spanish Society of Infectious Diseases and Clinical Microbiology]S Moreno, J Arrizabalaga, J M Gatell, et al.
Antiviral Research|June 16, 2000
Genetic evolution of GB virus C/hepatitis G virus (GBV-C/HGV) under interferon pressureM Giménez-Barcons, A Sánchez-Fueyo, S Ampurdanés, et al.
Journal of Dental Research|July 20, 2021
Mouthwashes with CPC Reduce the Infectivity of SARS-CoV-2 Variants In VitroJ Muñoz-Basagoiti, D Perez-Zsolt, R León, et al.
HIV Medicine|April 6, 2005
Comparison of gastrointestinal tolerability and patient preference for treatment with the 625 mg and 250 mg nelfinavir tablet formulationsM Johnson, L Nieto-Cisneros, A Horban, et al.
AIDS (London, England)|May 12, 2000
Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain. The ERASE-2 Study GroupT Puig, M Pérez-Olmeda, A Rubio, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|December 3, 1998
[Recommendations for antiretroviral treatment in 1998. AIDS Working Group of the Spanish Society for Infectious Diseases and Clinical Microbiology (SEIMC)]S Moreno, J Arrizabalaga, J M Gatell, et al.
Pageof 27